近10年成本-效用分析中EQ-5D与SF-6D应用现状的文献计量研究：基于PubMed数据库

摘要

Objective: To analyze the application status of the EQ-5D and SF-6D in cost-utility analysis ( CUA) . Methods: The data from PubMed data base from 2003-2012 was conducted as the main resource in econometric analysis. Results: There is no certain increasing trend of literature quantity in the recent 10 years’ application of EQ-5D and SF-6D in the CUA. The main published language was English and the main country was the United Kingdom. The core authors of researches on the CUA estimated by EQ-5D and SF-6D had not been formed, however, the core periodicals had been formed. The literatures involve wide-spread diseases, mainly known as Motion system and pain diseases. Most of the effectiveness could be calculated with quality adjusted life year ( QALY) , the object of CUA is mainly on the medicine, operation and health intervention. Conclusion: Appicating EQ-5D and SF-6D in CUA and research content of the literatures has wide distribution width, although it has shown centralized trend, which still needs more studies by related researchers.%目的：分析欧洲5维健康量表（EQ-5D）与6维健康调查短表(SF-6D)在成本-效用分析研究中的应用现状。方法：以PubMed数据库为数据源对2003-2012年发表的相关文献进行文献计量分析。结果：近10年应用EQ-5D与SF-6D进行成本-效用分析的文献量未呈一定的增长趋势，主要的发表语言为英语，主要国家为英国。已形成6种核心期刊，核心作者尚未形成。文献所涉及的疾病分布广泛，且主要是运动系统和疼痛类疾病。效用绝大多数采用质量调整生命年表示，成本-效用分析的评价对象主要集中于药物、手术和健康干预3种。结论：应用EQ-5D与SF-6D进行成本-效用分析的文献及文献所研究内容分布范围均较广，虽然已经呈现出集中趋势，但未形成核心，有待于相关领域学者开展广泛的研究。